Your browser doesn't support javascript.
loading
The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study.
Lew, Jie-Bin; Feletto, Eleonora; Worthington, Joachim; Roder, David; Canuto, Karla; Miller, Caroline; D'Onise, Katina; Canfell, Karen.
Afiliação
  • Lew JB; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia. Electronic address: JieBin.Lew@nswcc.org.au.
  • Feletto E; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia. Electronic address: eleonoraf@nswcc.org.au.
  • Worthington J; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia. Electronic address: Joachim.Worthington@nswcc.org.au.
  • Roder D; Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia. Electronic address: David.Roder@unisa.edu.au.
  • Canuto K; Wardliparingga Aboriginal Health Equity, South Australian Health and Medical Research Institute, Australia. Electronic address: Karla.Canuto@sahmri.com.
  • Miller C; Health Policy Centre, South Australian Health and Medical Research Institute, Australia; School of Public Health, University of Adelaide, Australia. Electronic address: Caroline.Miller@sahmri.com.
  • D'Onise K; School of Public Health, University of Adelaide, Australia; Prevention and Population Health, Wellbeing SA, Australia. Electronic address: Katina.d'onise@sa.gov.au.
  • Canfell K; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia. Electronic address: karen.canfell@nswcc.org.au.
J Cancer Policy ; 32: 100325, 2022 06.
Article em En | MEDLINE | ID: mdl-35560263
BACKGROUND: Australian Aboriginal and Torres Strait Islander peoples experience health and socioeconomic disparities, including lower life-expectancy, have a younger mean age of colorectal cancer (CRC) diagnosis, and lower CRC survival than non-Indigenous Australians. The National Bowel Cancer Screening Program (NBCSP) provides biennial CRC screening for Australians aged 50-74 years to reduce the burden of CRC. The 2019 participation rate was 42% nationwide and 23% in Aboriginal and Torres Strait Islander peoples. For Aboriginal and Torres Strait Islander peoples, this study aims to estimate the health outcomes and cost-effectiveness of the current NBCSP and extensions to include people < 50 years. METHODS: An existing microsimulation model, Policy1-Bowel, was adapted to the Aboriginal and Torres Strait Islander population and was used to evaluate three strategies assuming biennial iFOBT screening from 50-74, 45-74, or 40-74 years under two participation scenarios: 23% and 42% per screening round (psr.). RESULTS: At 23-42% participation psr., the current NBCSP was predicted to reduce lifetime CRC incidence and mortality by 14-24% and 23-39%, respectively, be cost-effective (incremental cost-effectiveness ratio <$13,000/life-year saved), and be associated with a benefits-and-burden balance of 51-53 number-needed-to-colonoscope (NNC) per CRC death prevented of . Lowering the screening start age to 40(45) would further reduce CRC incidence and CRC mortality by 7-11(4-5) percentage points, be cost-effective, and be associated with an incremental NNC- of > 95 (> 60). CONCLUSION: For Aboriginal and Torres Strait Islander peoples, the current NBCSP is cost-effective but participation is limited. Lowering the screening start age will further reduce CRC incidence and mortality. POLICY SUMMARY: These findings highlight a need to increase NBCSP participation whilst exploring the feasibility and acceptability of lowering the NBCSP start age for Aboriginal and Torres Strait Islander peoples. These findings could inform new co-designed, community-led strategies to improve CRC outcomes for Aboriginal and Torres Strait Islander peoples.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Havaiano Nativo ou Outro Ilhéu do Pacífico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Havaiano Nativo ou Outro Ilhéu do Pacífico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article